Skip to main content
Karger Author's Choice logoLink to Karger Author's Choice
. 2020 Oct 16;105(1-2):167–168. doi: 10.1159/000511787

Erratum

PMCID: PMC8006581  PMID: 33070133

In the article by Karabulut et al. entitled “The Effect of the Presence of Lower Urinary System Symptoms on the Prognosis of COVID-19: Preliminary Results of a Prospective Study” [Urol Int. DOI: 10.1159/000510761], an error occurred in Tables 1, 2, 3. The corrected Tables are shown below.

Table 1.

Comparison of demographic data, comorbidities, and COVID-19 symptoms between groups

Characteristics Group 1
(n = 22)
Group 2
(n = 22)
Group 3
(n = 19)
p
Demographic data
 Mean age, years 61.5 (46–75) 63.0 (47–78) 63.4 (48–78) 0.708a
 BMI, kg/m2 25.7 (22–29) 25.5 (22–29) 26.4 (22–28) 0.896a
Medical comorbidity
 Diabetes mellitus 5 6 5 0.936b
 Hypertension 7 6 5 0.914b
 COPD 6 7 6 0.935b
 Malignancy 2 2 2 0.984b
 COD 2 4 2 0.626b
 Others 5 5 3 0.823b
Symptoms
 Fever 19 18 16 0.918b
 Cough 16 17 15 0.887b
 Sore throat 12 16 15 0.211b
 Headache 10 11 15 0.068b
 Fatigue 15 14 15 0.555b
 Myalgia 3 8 9 0.058b
 Breathless 5c 6 11 0.04b

Data are expressed as a median (min–max) or n, unless indicated otherwise. COPD, chronic obstructive pulmonary disease; COD, chronic organ deficiency (liver, kidney, heart, etc.).

a

Kruskal-Wallis test.

b

Pearson χ2 test.

c

p < 0.05 Pearson χ2 test (with Group 3).

Table 2.

Comparison of I-PSS values, duration of hospitalization, requirement of critical care and mortality data between groups

Group 1
(n = 22)
Group 2
(n = 22)
Group 3
(n = 19)
p
I-PSS score 5.1 (2–7)c d 12.3 (8–18)c 27.5 (21–34) <0.001a
Duration of hospitalization, days 18.2 (l4–30)c 19.4 (14–30)c 23.1 (15–31) 0.005a
Requirement of critical care 4e 5e 10 0.036b
Mortality 1e 3 7 0.021b

Data are expressed as a median (min-max) or n.

a

Kruskal-Wallis test (Monte Carlo), post hoc test: Dunn's test.

b

Pearson χ2 test.

c

p < 0.05 Kruskal-Wallis test (with Group 3).

d

p < 0.05 Kruskal-Wallis test (with Group 2).

e

p < 0.05 Pearson χ2 test (with Group 3).

Table 3.

Number of patients not requiring critical care by time

Time
0 h 0–3 h 3–6 h 6–9 h 9–12 h >12 h
Group 1a 22 22 22 19 16 16
Group 2b 22 22 22 13 12 12
Group 3c 19 19 12 8 8 8
a

I-PSS score: 0–7.

b

I-PSS score: 8–19.

c

I-PSS score: 20–35.


Articles from Urologia Internationalis are provided here courtesy of Karger Publishers

RESOURCES